By Dr Kristina Warton

Book Chapters

Warton K; Stirzaker C; Samimi G; Clark S, 2022, 'DNA Methylation Analysis of Circulating DNA Biomarkers', in Cell-Free Circulating DNA: Purification and Analysis Techniques, pp. 247 - 277, http://dx.doi.org/10.1142/9789811244681_0009

Mahon K; Samimi G; Warton K, 2022, 'Considerations in Biobanking Blood Samples and Plasma Volume for Circulating DNA Studies', in Cell-Free Circulating DNA, WORLD SCIENTIFIC, pp. 47 - 62, http://dx.doi.org/10.1142/9789811244681_0003

Journal articles

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford CE, 2024, 'Accurate Identification of Cancer Cells in Complex Pre-Clinical Models Using a Deep-Learning Neural Network: A Transfection-Free Approach', Advanced Biology, 8, http://dx.doi.org/10.1002/adbi.202400034

Werner B; Powell E; Duggan J; Cortesi M; Lee YC; Arora V; Athavale R; Dean M; Warton K; Ford CE, 2024, 'Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer', Molecular Oncology, 18, pp. 2668 - 2683, http://dx.doi.org/10.1002/1878-0261.13710

Werner B; Powell E; Duggan J; Cortesi M; Lee YC; Arora V; Athavale R; Dean M; Warton K; Ford C, 2024, 'Use of cell-free DNA from ascites to identify variants and tumour evolution in a cohort of patients with advanced ovarian cancer.', Journal of Clinical Oncology, 42, pp. 5547 - 5547, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.5547

Werner B; Sjoquist KM; Espinoza D; Yip S; Chang G; Cummins MM; Mileshkin L; Ananda S; Shannon C; Friedlander M; Warton K; Ford CE, 2024, 'Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial', Translational Oncology, 43, http://dx.doi.org/10.1016/j.tranon.2024.101914

Fisher T; Powell E; Yuwono NL; Ford CE; Warton K, 2024, 'Circulating cell-free DNA is elevated in postmenopausal compared with pre- and perimenopausal women', Menopause, 31, pp. 171 - 175, http://dx.doi.org/10.1097/GME.0000000000002313

Cortesi M; Warton K; Ford CE, 2024, 'Beyond 2D cell cultures: how 3D models are changing the in vitro study of ovarian cancer and how to make the most of them', PeerJ, 12, http://dx.doi.org/10.7717/peerj.17603

Werner B; Sjoquist KM; Espinoza D; Yip S; Chang G; Cummins MM; Mileshkin LR; Ananda S; Shannon CM; Friedlander M; Warton K; Ford C, 2023, 'Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response: A translational sub-study of the REZOLVE (ANZGOG-1101) clinical trial.', Journal of Clinical Oncology, 41, pp. 5561 - 5561, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.5561

Yuwono NL; Alonso A; Abbott J; Houshdaran S; Henry CE; Rodgers R; Ford CE; Warton K, 2022, 'Circulating cell-free endometrial DNA level is unaltered during menstruation and in endometriosis', Human Reproduction, 37, pp. 2560 - 2569, http://dx.doi.org/10.1093/humrep/deac198

Werner B; Warton K; Ford CE, 2022, 'Endogenous cell-free DNA in fetal bovine serum introduces artifacts to in vitro cell-free DNA models', BioTechniques, 73, pp. 219 - 226, http://dx.doi.org/10.2144/btn-2022-0040

Fisher T; Ford CE; Warton K, 2022, 'Recovery Efficiency of Cell-Free DNA After Bisulfite Conversion', Clinical Chemistry, 68, pp. 1219 - 1220, http://dx.doi.org/10.1093/clinchem/hvac107

Yuwono NL; Boyd MAA; Henry CE; Werner B; Ford CE; Warton K, 2022, 'Circulating cell-free DNA undergoes significant decline in yield after prolonged storage time in both plasma and purified form', Clinical Chemistry and Laboratory Medicine, 60, pp. 1287 - 1298, http://dx.doi.org/10.1515/cclm-2021-1152

Alonso A; Yuwono NL; Houshdaran S; Abbott J; Rodgers R; Ford CE; Warton K, 2022, 'Comparison of total and endometrial circulating cell-free DNA in women with and without endometriosis', Reproductive BioMedicine Online, 44, pp. 495 - 503, http://dx.doi.org/10.1016/j.rbmo.2021.11.006

Werner B; Warton K; Ford CE, 2022, 'Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology', Cancers, 14, http://dx.doi.org/10.3390/cancers14051309

Hossain KR; Escobar Bermeo JD; Warton K; Valenzuela SM, 2022, 'New Approaches and Biomarker Candidates for the Early Detection of Ovarian Cancer.', Front Bioeng Biotechnol, 10, pp. 819183, http://dx.doi.org/10.3389/fbioe.2022.819183

Yuwono NL; Warton K; Ford CE, 2021, 'The influence of biological and lifestyle factors on circulating cell-free dna in blood plasma', eLife, 10, http://dx.doi.org/10.7554/eLife.69679

Werner B; Yuwono N; Duggan J; Liu D; David C; Srirangan S; Provan P; DeFazio A; Arora V; Farrell R; Lee YC; Warton K; Ford C, 2021, 'Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer', Gynecologic Oncology, 162, pp. 720 - 727, http://dx.doi.org/10.1016/j.ygyno.2021.06.028

Hagstrom AD; Yuwono N; Warton K; Ford CE, 2021, 'Sex Bias in Cohorts Included in Sports Medicine Research', Sports Medicine, 51, pp. 1799 - 1804, http://dx.doi.org/10.1007/s40279-020-01405-6

Yuwono NL; Henry CE; Ford CE; Warton K, 2021, 'Total and endothelial cell-derived cell-free DNA in blood plasma does not change during menstruation', PLoS ONE, 16, http://dx.doi.org/10.1371/journal.pone.0250561

Ford CE; Werner B; Hacker NF; Warton K, 2020, 'The untapped potential of ascites in ovarian cancer research and treatment', British Journal of Cancer, 123, pp. 9 - 16, http://dx.doi.org/10.1038/s41416-020-0875-x

Warton K; Xu Y; Ford CE, 2020, 'Target sequence heterogeneity causes the 'hook effect' in fluorescent dye-based quantitative PCR', BioTechniques, 69, pp. 81 - 84, http://dx.doi.org/10.2144/BTN-2020-0016

Werner B; Yuwono NL; Henry C; Gunther K; Rapkins RW; Ford CE; Warton K, 2019, 'Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight', PLoS ONE, 14, http://dx.doi.org/10.1371/journal.pone.0224338

Warton K; Graham LJ; Yuwono N; Samimi G, 2018, 'Comparison of 4 commercial kits for the extraction of circulating DNA from plasma', Cancer Genetics, 228-229, pp. 143 - 150, http://dx.doi.org/10.1016/j.cancergen.2018.02.004

Warton K; Yuwono NL; Cowley MJ; McCabe MJ; So A; Ford CE, 2017, 'Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma', Molecular Diagnosis and Therapy, 21, pp. 563 - 570, http://dx.doi.org/10.1007/s40291-017-0284-x

Warton K; Mahon KL; Samimi G, 2016, 'Methylated circulating tumor DNA in blood: Power in cancer prognosis and response', Endocrine-Related Cancer, 23, pp. R157 - R171, http://dx.doi.org/10.1530/ERC-15-0369

Warton K; Samimi G, 2015, 'Methylation of cell-free circulating DNA in the diagnosis of cancer', Frontiers in Molecular Biosciences, 2, http://dx.doi.org/10.3389/fmolb.2015.00013

Warton K; Lin V; Navin T; Armstrong NJ; Kaplan W; Ying K; Gloss B; Mangs H; Nair SS; Hacker NF; Sutherland RL; Clark SJ; Samimi G, 2014, 'Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma', BMC Genomics, 15, http://dx.doi.org/10.1186/1471-2164-15-476

Warton K; Vita L; Armstrong NJ; Kaplan W; Ying K; Mangs H; Hacker NF; Sutherland RL; Clark SJ; Samimi G, 2013, 'Whole genome sequencing of free circulating DNA from plasma of HGSOC patients', CLINICAL CANCER RESEARCH, 19, http://dx.doi.org/10.1158/1078-0432.OVCA13-A4

Montavon C; Gloss B; Warton K; Barton CA; Statham AL; Scurry J; Tabor B; Nguyen TV; Qu WJ; Samimi G; Hacker NF; Sutherland RL; Clark SJ; O'Brien P, 2012, 'Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer', Gynecologic Oncology, 124, pp. 582 - 588, http://dx.doi.org/10.1016/j.ygyno.2011.11.026

Thompson EW; Warton K; Blick T; Wafai R; Hill P; Stanley K, 2010, 'Multiplexed tandem polymerase chain reaction identifies strong expression of oestrogen receptor and Her-2 from single, formalin-fixed, paraffin-embedded breast cancer sections', Pathology, 42, pp. 165 - 172, http://dx.doi.org/10.3109/00313020903494102

van Bockel D; Price DA; Asher TE; Venturi V; Suzuki K; Warton K; Davenport MP; Cooper DA; Douek DC; Kelleher AD, 2007, 'Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood', Journal of Immunological Methods, 326, pp. 127 - 138, http://dx.doi.org/10.1016/j.jim.2007.07.016

Gurisik E; Warton K; Martin DK; Valenzuela SM, 2006, 'An in vitro study of the effects of exposure to a GSM signal in two human cell lines: Monocytic U937 and neuroblastoma SK-N-SH', Cell Biology International, 30, pp. 793 - 799, http://dx.doi.org/10.1016/j.cellbi.2006.06.001

Warton K; Foster NC; Gold WA; Stanley K, 2004, 'A novel gene family induced by acute inflammation in endothelial cells', Gene, 342, pp. 85 - 95, http://www.sciencedirect.com/science/article/B6T39-4DCMP89-5/2/314ad22d29d760d4250b2af4878e8a94

Warton K; Tonini R; Fairlie WD; Matthews JM; Valenzuela SM; Qiu MR; Wu WM; Pankhurst S; Bauskin AR; Harrop SJ; Campbell TJ; Curmi PM; Breit SN; Mazzanti M, 2002, 'Recombinant CLIC1 (NCC27) assembles in lipid bilayers via a pH-dependent two-state process to form chloride ion channels with identical characteristics to those observed in Chinese Hamster Ovary cells expressing CLIC1', The Journal of Biological Chemistry, 277, pp. 26003 - 26011

Harrop SJ; Demaere MZ; Fairlie WD; Reztsova T; Valenzuela SM; Mazzanti M; Tonini R; Qiu MR; Jankova L; Warton K; Bauskin AR; Wu WM; Pankhurst S; Campbell TJ; Breit SN; Curmi PM, 2001, 'Crystal structure of a soluble form of the Intracellular Chloride Ion Channel CLIC1 (NCC27) at 1.4-A resolution', The Journal of Biological Chemistry, pp. 44993 - 45000

Valenzuela SM; Mazzanti M; Tonini R; Qiu MR; Warton K; Musgrove EA; Campbell TJ; Breit SN, 2000, 'The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycle', Journal of Physiology, 529, pp. 541 - 552, http://dx.doi.org/10.1111/j.1469-7793.2000.00541.x

Warton K; Valenzuela S; Tonini R; Mazzanti M; Breit S, 2000, 'Intracellular Ion Channel NCC27 Moves between a Soluble and a Transmembrane State', Biochemical Society Transactions, 28, pp. A471 - A471, http://dx.doi.org/10.1042/bst028a471c

Tonini R; Ferroni A; Valenzuela SM; Warton K; Campbell TJ; Breit SN; Mazzanti M, 2000, 'Functional characterization of the NCC27 nuclear protein in stable transfected CHO-K1 cells', Federation of American Societies for Experimantal Biology Journal, 14, pp. 1171 - 1178

Ludowyke RI; Warton K; Scurr LL, 1998, 'Inhibition of antigen and calcium ionophore induced secretion from RBL-2H3 cells by phosphatase inhibitors', Cell Biology International, 22, pp. 855 - 865, http://dx.doi.org/10.1006/cbir.1998.0332

Valenzuela SM; Martin DJ; Warton K; Por SB; Robbins JM; Bootcov MR; Schofield PR; Campbell TJ; Breit SN, 1997, 'Molecular cloning and expression of a chloride ion channel of cell nuclei.', The Journal of Biological Chemistry, pp. 12575 - 12582

Conference Papers

Werner B; Powell E; Duggan J; Lee YC; Athavale R; Dean M; Warton K; Ford C, 2023, 'PR004/#458  Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in a cohort of patients with advanced ovarian cancer', in Featured Posters: Poster Rounds with the Professors, BMJ Publishing Group Ltd, pp. A32.2 - A33, presented at IGCS 2023 Annual Meeting Abstracts, http://dx.doi.org/10.1136/ijgc-2023-igcs.47

Warton K; Yuwono N; Henry C; Hacker N; Ford C, 2020, 'Abstract B28: Optimizing DNA processing and ovarian cancer methylation-specific PCR assays for the detection of early-stage ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. B28 - B28, http://dx.doi.org/10.1158/1557-3265.ovca19-b28

Mazzanti M; Warton K; Tonini R; Lorenzi G; Fairlie D; Matthews JM; Valenzuela S; Qiu MR; Wu WM; Pankhurst S; Bauskin AR; Campbell TJ; Curmi PMG; Breit SN, 2002, 'NCC27 (CLIC1) interacts with artifical bylayer in a pH dependent manner to form chloride ion channels', in BIOPHYSICAL JOURNAL, BIOPHYSICAL SOCIETY, pp. 244A - 244A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000173252701198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Yuwono NL; Warton K; Henry C; Ford C, 2020, 'Deciphering the origin of circulating cell-free DNA and its alterations during menstruation', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-731

Preprints

Cortesi M; Li J; Liu D; Guo T; Dokos S; Warton K; Ford C, 2024, A novel approach for the quantification of single-cell adhesion dynamics from microscopy images, http://dx.doi.org/10.1101/2024.10.08.616409

Werner B; Powell E; Duggan J; Cortesi M; Lee YC; Arora V; Athavale R; Dean M; Warton K; Ford C, 2024, Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer, http://dx.doi.org/10.1101/2024.03.09.24303840

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Giordano E; Ford C, 2024, Development and validation of a computational tool to predict treatment outcomes in cells from High-Grade Serous Ovarian Cancer patients, http://dx.doi.org/10.1101/2024.10.02.616212

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford C, 2023, Accurate identification of cancer cells in complex pre-clinical models using deep-learning: a transfection-free approach, http://dx.doi.org/10.1101/2023.10.15.562411

Back to profile page